SCHEMBL6567213

SCHEMBL6567213

Cc1c(Cl)cc(NCc2ccc(C#N)cc2)c(O)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.44
VNN1 O95497 2/20 0.39
PDE5A O76074 6/20 0.39
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
CACNA1B Q00975 2/20 0.36
AKR1B1 P15121 1/20 0.36
CYP2A6 P11509 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KLKB1 P03952 1/20 0.35
KLK1 P06870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351839 0.82 HDAC8 (0.45) KDM4EALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL4346813 0.80 KMT2A (0.48) KDM4EALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL6566872 0.77 CA1 (0.51) LOXL2ALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL4345563 0.76 BRD4 (0.49) CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6566907 0.75 POLB (0.50) KDM4EALDH1A1HPGDLMNAHTT
SCHEMBL4355634 0.74 MAPT (0.56) KDM4EALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL10873553 0.72 LOXL2 (0.49) LOXL2VNN1MMP2MMP3KDM4E
SCHEMBL4349831 0.71 RXFP1 (0.46) CYP1A2CYP2D6HPGDCYP2C19LMNA
SCHEMBL6568648 0.70 LMNA (0.41) KDM4EALDH1A1CYP2C9HPGDLMNA
SCHEMBL4357552 0.70 HDAC8 (0.47) KDM4EALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed